Fertility Test Market Analysis and Forecast to 2032: By Product (Ovulation Prediction Kits, Fertility Monitors, Male Fertility Test Kits), Mode of Purchase (OTC-based, Prescription-based, Online), Application (Female Fertility Testing, Male Fertility Test

Fertility Test Market Analysis and Forecast to 2032: By Product (Ovulation Prediction Kits, Fertility Monitors, Male Fertility Test Kits), Mode of Purchase (OTC-based, Prescription-based, Online), Application (Female Fertility Testing, Male Fertility Testing), End User (Home Care Settings, Fertility Clinics), and Region

The global fertility test market was valued at USD 472 million in 2022 and it is anticipated to grow further up to USD 979.9 million by 2032, at a CAGR of 7.6% during the forecast period.

A medical and physical assessment called a fertility test measures a person's capacity to conceive naturally. Growing older is one of the factors that might impair fertility, therefore women and men who are 35 or older who are having trouble becoming pregnant even after six months of trying should think about fertility testing. Blood tests, discussions of medical history, and minimally invasive procedures are all part of the fertility testing procedure. It mostly includes detecting hormones like luteinizing hormone or progesterone hormone in blood, urine, or saliva to determine whether ovulation has occurred. Semen analysis is part of the tests for males to ensure a proper sperm count.

Global Fertility Test Market Scope and Report Structure

Market Trends and Drivers

The increasing first-time pregnancy age is propelling the growth of the market. Due to the drop in first pregnancies among teenage girls and the rise in pregnancies among women over 30, the average age of first pregnancies has dramatically increased globally during the past few decades. The average age at which women give birth is now 30 or older, according to the OECD; this development is primarily being noticed since women over the world are showing a higher preference for delaying first pregnancies. Listed below are some significant products launched in recent years:

• The average mean age of a first pregnancy in the OECD-25 nations climbed from 29 to 30 between 2015 and 2019 according to the OECD Family Database. The only OECD nation with a mean average age of 28 or less is Mexico.
• Only 11.8 births per 1,000 young women (under the age of 20) have their first child, which is in line with the rising mean age of first-time pregnancies (Source: OECD).
• UNICEF reports that between 2005 and 2017, the average age of Canadian women giving birth to their first child rose by 1.5 years, from 27.5 to 29.
• The average age of first-time moms in the Netherlands grew from 29.4 years in 2013 to 29.9 years in 2019. (Source: CBS, 2019).

Market Restraints and Challenges

The lesser precision of ovulation prediction kits is anticipated to hinder the growth of the market during the forecast period. The luteinizing hormone (LH) spike that occurs 24-36 hours before ovulation is measured by ovulation prediction kits. However, ovulation cannot be precisely confirmed using these kits. Ovulation predictors are not reliable in cases like luteinized unruptured follicle syndrome, which happens when a woman's egg does not break free from her follicle after the LH surge. Additionally, urinary LH measurement only predicts the beginning of ovulation and cannot pinpoint the day of ovulation or anovulation, indicating a very brief window of opportunity for conception.

Only LH can be detected by ovulation monitors; they are unable to detect other crucial ovulation indicators, such as if the cervical mucous is conducive to fertilization. Additionally, these monitors are ineffective in the presence of the hormone hCG (Human Chorionic Gonadotropin) or some fertility medications like Personal in the urine. The fact that these kits do not work for women in their 40s (particularly those who are close to menopause) due to elevated levels of LH is another significant disadvantage. These drawbacks of ovulation monitors reduce their predictive power, which is preventing end users from using them.

Global Fertility Test Market Segmental Overview

The report analyses the global fertility test market based on product, mode of purchase, application, end user, and region.

Global Fertility Test Market by Product

By product, it is segmented into ovulation prediction kits, fertility monitors, and male fertility test kits. The ovulation prediction kits segment is likely to dominate the market during the forecast period. The key factors such as the increase in the use of ovulation prediction kits coupled with the easy availability of the over-the-counter test kits for at-home testing are boosting the growth of the market.

Global Fertility Test Market by Mode of Purchase

By mode of purchase, it is segmented into direct/prescription-based products, OTC-based products, and online products. The OTC segment is anticipated to register significant growth during the forecast period. The high growth of this segment is attributed to the inclination of patients towards self-monitoring of healthcare conditions coupled with increasing initiatives by market players to spread awareness on fertility, and the rising preference for confidentiality and accessibility of test results is also boosting the growth of the market.

Global Fertility Test Market by Application

By application, it is segmented into female fertility testing and male fertility testing. The female fertility testing segment is likely to dominate the market during the forecast period. The key factors such as the availability of a wide range of fertility testing products for females coupled with technologically advanced testing kits which predicts accurate ovulation date and decreasing female fertility rates is boosting the growth of the market.

Global Fertility Test Market by End User

By end user, it is segmented into home care settings, hospitals & fertility clinics. The home care settings segment is likely to dominate the market during the forecast period. The large share and high growth of this segment can be attributed to the inclination of patients toward self-monitoring of healthcare conditions coupled with easy access to fertility and ovulation monitors on e-commerce websites, availability of user-friendly and easy-to-handle devices, and the growing preference for confidentiality of test results.

Geographical Analysis of the Global Fertility Test Market

Region-wise, it is studied across North America, Europe, Asia Pacific, and the Rest of the World. The North American region is likely to dominate the market during the forecast period. The large share of this region can be primarily attributed to factors such as the high prevalence of infertility coupled with increasing awareness about fertility testing among women, the rising age of first-time pregnancies in women, and the easy availability of ovulation and fertility monitors through e-commerce websites.

Major Players in the Global Fertility Test Market

The key players studied in the global fertility test market are Swiss Precision Diagnostics (Switzerland), Church & Dwight (US), Prestige Brands Holdings (US), bioZhena (US), Fairhaven Health (US), Fertility Focus (UK), Geratherm Medical (Germany), Hilin Life Products (US), UEBE Medical (Germany),  AdvaCare Pharma (US),  AVA (Switzerland), Babystart (UK), Valley Electronics (Germany)and Mira Care (US).

COVID-19 Impact

The COVID-19 pandemic has emerged as a huge challenge for the global fertility market. In the initial stages of the pandemic, authorities recommended the suspension of all in-person fertility treatments. For instance, in March 2020, the American Society of Reproductive Medicine and the Canadian Fertility and Andrology Society announced their recommendations to instantly and for the foreseeable future suspend all in-person fertility treatments in the US and Canada due to COVID-19.

Infertility affects one in six couples of childbearing age, and many turn to procedures like IUI and IVF, which take multiple in-person consultations to accomplish. Only 0.5 million persons in India receive IVF/Intrauterine Insemination (IUI) therapy each year out of the country's 3 million annual infertility treatment requests. According to data, between April and June 2020, there was a 90% decrease in the number of IVF cycles performed at the 1,100 clinics spread throughout India. This information suggests that numerous couples have stopped their IVF cycles. This circumstance has led to a rise in the use of alternative testing and planning tools including ovulation prediction kits and fertility monitors. The use of ovulation monitors, fertility testing tools, and fertility trackers on e-commerce websites has risen consumers for the products.

Recent Developments

• February 2021, Fertility Focus partnered with ExSeed Health, a home-based sperm testing company. Under this partnership, both companies would together provide solutions to couples planning a pregnancy.
• May 2019, Fertility Focus launched an updated version of Ovu Sense App- Ovu Sense App V.2 with features such as increased flexibility in data viewing, more choices for logging events than most of the apps, and increased accuracy in terms of monitoring cycles.
• December 2018, Concepta Diagnostics launched my Lotus Fertility app and monitoring system which was useful for women trying to conceive by testing their ovulation period at home.
• January 2017, NFI Consumer Healthcare, a division of Gregory Pharmaceutical Holdings, completed the acquisition of the e.p.t. OTC pregnancy.

Frequently Asked Questions

Q1.

How big is the Fertility Test market?

Ans.

The global fertility test market was valued at USD 472 million in 2022 and it is anticipated to grow further up to USD 979.9 million by 2032, at a CAGR of 7.6% during the forecast period.

Q2.

What is the Fertility Test market growth rate?

Ans.

The growth rate of the Fertility Test market is 7.6%.

Q3.

Which region holds a major market share for the Fertility Test market?

Ans.

North America holds a major market share of the Fertility Test market in 2021.

Q4.

Which segment accounted for the largest Fertility Test market share?

Ans.

By end user, home care settings segment accounted for the largest Fertility Test market share.

Q5.

Who are the key players in the Fertility Test market?

Ans.

The global Fertility Test market report includes players such as Swiss Precision Diagnostics (Switzerland), Church & Dwight (US), Prestige Brands Holdings (US), bioZhena (US), Fairhaven Health (US), Fertility Focus (UK), Geratherm Medical (Germany), Hilin Life Products (US), UEBE Medical (Germany), AdvaCare Pharma (US), AVA (Switzerland), Babystart (UK), Valley Electronics (Germany), Sensiia (UK), and Mira Care (US) among others.

Q6.

What are the factors driving the Fertility Test market growth?

Ans.

The major factors driving the growth of the market are the growing healthcare market in emerging countries.

Q7.

What are the key growth strategies of Fertility Test market players?

Ans.

The key growth strategies of Fertility Test market players are product launch and product approval.
Q8. Which region will provide more business opportunities for the Fertility Test market during the forecast period?

Ans.

The Asia-Pacific region will provide more business opportunities for the Fertility Test market during the forecast period.

Please Note: This report will be delivered by publisher within 3-4 business days of order confirmation.